malignant solid neoplasm
Showing 26 - 50 of 168
Childhood Cancer, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in San Francisco (Survivorship mobile
Recruiting
- Childhood Cancer
- +2 more
- Survivorship mobile application
- Questionnaires
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 1, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Letermovir)
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Letermovir
- (no location specified)
Jan 23, 2023
Atypical Teratoid/Rhabdoid Tumor, Epithelioid Sarcoma, Kidney Medullary Carcinoma Trial (Atezolizumab, Tiragolumab)
Recruiting
- Atypical Teratoid/Rhabdoid Tumor
- +17 more
- Atezolizumab
- +7 more
-
Birmingham, Alabama
- +19 more
Feb 2, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Canada, United States (other, device, behavioral)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Educational Intervention
- +5 more
-
Mobile, Alabama
- +110 more
Jan 30, 2023
Following COVID-19 Vaccination in Children, Adolescents, and
Recruiting
- COVID-19 Infection
- +2 more
- Biospecimen Collection
- Survey Administration
-
Birmingham, Alabama
- +54 more
Jan 30, 2023
Malignant Solid Tumor, Recurrent Adrenal Gland Pheochromocytoma, Recurrent Ectomesenchymoma Trial in Puerto Rico, United States
Recruiting
- Malignant Solid Neoplasm
- +40 more
- Biospecimen Collection
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 27, 2023
COVID-19 Infection, Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Seattle (Questionnaire Administration,
Suspended
- COVID-19 Infection
- +2 more
- Questionnaire Administration
- Sotrovimab
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 24, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial (Biospecimen Collection, Vincristine)
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Vincristine
-
Birmingham, Alabama
- +20 more
Jan 23, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Philadelphia (Magnetic Resonance Imaging, Computed
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Magnetic Resonance Imaging
- +4 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 20, 2023
Molecular Testing for MD Anderson Cancer Center Personalized
Recruiting
- Glioma
- +4 more
- Biospecimen Collection
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Role of Gut Microbiome in Cancer Therapy
Active, not recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Biospecimen Collection
- Electronic Health Record Review
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 18, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor, Nasal Vestibulitis Trial in United States (Placebo Administration,
Completed
- Hematopoietic and Lymphoid Cell Neoplasm
- +2 more
- Placebo Administration
- +2 more
-
Albert Lea, Minnesota
- +19 more
Jan 18, 2023
Radiation Therapy, The PRO-RT Study
Recruiting
- Breast Carcinoma
- +3 more
- Electronic Health Record Review
- +2 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Jan 16, 2023
Head and Neck Squamous Cell Carcinoma, Malignant Solid Tumor Trial in Houston (Alisertib, Pembrolizumab)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Malignant Solid Neoplasm
- Alisertib
- Pembrolizumab
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Adenovirus Infection, BK Virus Infection, Cytomegaloviral Infection Trial in Houston (Virus-specific Cytotoxic T-lymphocytes)
Recruiting
- Adenovirus Infection
- +6 more
- Virus-specific Cytotoxic T-lymphocytes
-
Houston, TexasM D Anderson Cancer Center
Jan 6, 2023
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Active, not recruiting
- COVID-19 Infection
- Malignant Solid Neoplasm
- Biospecimen Collection
- Electronic Health Record Review
-
Jacksonville, FloridaMayo Clinic in Florida
Jan 6, 2023
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Houston (6 Minute Walk Functional Test, Behavioral
Recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- 6 Minute Walk Functional Test
- +3 more
-
Houston, Texas
- +1 more
Jan 6, 2023
Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial in Scottsdale (Counseling, Discussion, Informational
Not yet recruiting
- Hematopoietic and Lymphoid System Neoplasm
- Malignant Solid Neoplasm
- Counseling
- +5 more
-
Scottsdale, ArizonaMayo Clinic in Arizona
Jan 4, 2023
Chemo-Induced Peripheral Neuropathy, Malignant Solid Tumor Trial in Rochester (Cannabidiol, Placebo Administration,
Recruiting
- Chemotherapy-Induced Peripheral Neuropathy
- Malignant Solid Neoplasm
- Cannabidiol
- +3 more
-
Albert Lea, Minnesota
- +5 more
Jan 4, 2023
Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer
Recruiting
- Adrenal Gland Pheochromocytoma
- +3 more
- Computed Tomography
- +2 more
-
Bethesda, Maryland
- +1 more
Jan 3, 2023
Advanced Clear Cell Renal Cell Carcinoma, Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant, Infiltrating Bladder
Active, not recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- +35 more
- Cabozantinib S-malate
- +2 more
-
Duarte, California
- +7 more
Jan 3, 2023
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Malignant Solid Tumor Trial in
Active, not recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +4 more
- Dabrafenib
- +4 more
-
Phoenix, Arizona
- +48 more
Jan 3, 2023
Collecting Blood and Tissue Sample Donations for Research for
Not yet recruiting
- Anal Carcinoma
- +11 more
- Biospecimen Collection
- (no location specified)
Dec 21, 2022
Hematopoietic and Lymphoid Cell Tumor, Malignant Solid Tumor Trial in Nashville (Itacitinib, Corticosteroid, Endoscopic
Not yet recruiting
- Hematopoietic and Lymphoid Cell Neoplasm
- Malignant Solid Neoplasm
- Itacitinib
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Dec 20, 2022